MAPS

MAPS
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $42.176M ▼ | $38.099M ▼ | $2.46M ▲ | 5.833% ▲ | $0.02 ▲ | $6.722M ▲ |
| Q2-2025 | $44.847M ▲ | $40.598M ▲ | $1.427M ▼ | 3.182% ▼ | $0.013 ▼ | $6.074M ▼ |
| Q1-2025 | $44.612M ▼ | $39.724M ▼ | $1.647M ▼ | 3.692% ▼ | $0.016 ▼ | $6.611M ▼ |
| Q4-2024 | $47.67M ▲ | $40.828M ▲ | $2.351M ▼ | 4.932% ▼ | $0.024 ▼ | $8.674M ▼ |
| Q3-2024 | $46.552M | $39.166M | $3.332M | 7.158% | $0.034 | $9.62M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $62.591M ▲ | $192.911M ▲ | $57.553M ▼ | $56.908M ▲ |
| Q2-2025 | $58.951M ▲ | $188.066M ▲ | $60.062M ▼ | $52.739M ▲ |
| Q1-2025 | $53.275M ▲ | $183.829M ▲ | $60.113M ▼ | $48.465M ▲ |
| Q4-2024 | $51.966M ▲ | $181.866M ▲ | $61.799M ▲ | $36.077M ▲ |
| Q3-2024 | $45.043M | $173.568M | $58.578M | $29.547M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $3.641M ▲ | $0 ▼ | $0 ▲ | $0 ▲ | $0 ▼ | $0 ▼ |
| Q2-2025 | $1.427M ▼ | $11.061M ▲ | $-2.843M ▲ | $-2.542M ▼ | $5.676M ▲ | $8.218M ▲ |
| Q1-2025 | $2.494M ▲ | $5.664M ▼ | $-3.65M ▼ | $-705K ▼ | $1.309M ▼ | $2.014M ▼ |
| Q4-2024 | $2.351M ▼ | $9.401M ▲ | $-2.138M ▲ | $-340K ▲ | $6.923M ▲ | $7.263M ▲ |
| Q3-2024 | $6.515M | $7.221M | $-2.359M | $-1.111M | $3.751M | $4.862M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Product and Service Other | $10.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
Service | $80.00M ▲ | $40.00M ▼ | $40.00M ▲ | $40.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
MAPS sits at the intersection of cannabis and technology, with a well-known consumer brand and a broad software suite supporting licensed operators. Financially, it has moved from volatility and a sizable loss toward modest profitability and steady positive cash flow, but on a relatively small base, leaving limited room for major missteps. The balance sheet is lean but not distressed, and cash flows suggest the business can largely fund itself if current trends hold. Competitively, network effects, regulatory expertise, and integration into retailer operations provide a real moat, though the cannabis industry’s regulatory and pricing pressures keep the environment challenging and unpredictable. Innovation is centered on deeper integration, data and analytics, and expansion into adjacent cannabis-related verticals, with an eye toward becoming the default operating system for the industry. The potential take-private transaction is an important wild card, as it could reshape governance, strategy, and how aggressive the company can be with long-term investments. Overall, MAPS appears to be in a stabilization and refinement phase: solidifying its core business, improving efficiency, and cautiously building on its early-mover advantage in a still-evolving market.
NEWS
November 26, 2025 · 7:00 AM UTC
Optimi Health to Supply MDMA to MAPS Israel's Clinical Trial for Trauma-Related PTSD
Read more
November 6, 2025 · 4:05 PM UTC
WM Technology, Inc. Reports Financial Results for Third Quarter 2025
Read more
October 23, 2025 · 4:05 PM UTC
WM Technology, Inc. to Announce Third Quarter 2025 Financial Results via Webcast
Read more
About WM Technology, Inc.
https://www.weedmaps.comWM Technology, Inc. provides ecommerce and compliance software solutions to retailers and brands in cannabis market in the United States, Canada, and internationally.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $42.176M ▼ | $38.099M ▼ | $2.46M ▲ | 5.833% ▲ | $0.02 ▲ | $6.722M ▲ |
| Q2-2025 | $44.847M ▲ | $40.598M ▲ | $1.427M ▼ | 3.182% ▼ | $0.013 ▼ | $6.074M ▼ |
| Q1-2025 | $44.612M ▼ | $39.724M ▼ | $1.647M ▼ | 3.692% ▼ | $0.016 ▼ | $6.611M ▼ |
| Q4-2024 | $47.67M ▲ | $40.828M ▲ | $2.351M ▼ | 4.932% ▼ | $0.024 ▼ | $8.674M ▼ |
| Q3-2024 | $46.552M | $39.166M | $3.332M | 7.158% | $0.034 | $9.62M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $62.591M ▲ | $192.911M ▲ | $57.553M ▼ | $56.908M ▲ |
| Q2-2025 | $58.951M ▲ | $188.066M ▲ | $60.062M ▼ | $52.739M ▲ |
| Q1-2025 | $53.275M ▲ | $183.829M ▲ | $60.113M ▼ | $48.465M ▲ |
| Q4-2024 | $51.966M ▲ | $181.866M ▲ | $61.799M ▲ | $36.077M ▲ |
| Q3-2024 | $45.043M | $173.568M | $58.578M | $29.547M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $3.641M ▲ | $0 ▼ | $0 ▲ | $0 ▲ | $0 ▼ | $0 ▼ |
| Q2-2025 | $1.427M ▼ | $11.061M ▲ | $-2.843M ▲ | $-2.542M ▼ | $5.676M ▲ | $8.218M ▲ |
| Q1-2025 | $2.494M ▲ | $5.664M ▼ | $-3.65M ▼ | $-705K ▼ | $1.309M ▼ | $2.014M ▼ |
| Q4-2024 | $2.351M ▼ | $9.401M ▲ | $-2.138M ▲ | $-340K ▲ | $6.923M ▲ | $7.263M ▲ |
| Q3-2024 | $6.515M | $7.221M | $-2.359M | $-1.111M | $3.751M | $4.862M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Product and Service Other | $10.00M ▲ | $0 ▼ | $0 ▲ | $0 ▲ |
Service | $80.00M ▲ | $40.00M ▼ | $40.00M ▲ | $40.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
MAPS sits at the intersection of cannabis and technology, with a well-known consumer brand and a broad software suite supporting licensed operators. Financially, it has moved from volatility and a sizable loss toward modest profitability and steady positive cash flow, but on a relatively small base, leaving limited room for major missteps. The balance sheet is lean but not distressed, and cash flows suggest the business can largely fund itself if current trends hold. Competitively, network effects, regulatory expertise, and integration into retailer operations provide a real moat, though the cannabis industry’s regulatory and pricing pressures keep the environment challenging and unpredictable. Innovation is centered on deeper integration, data and analytics, and expansion into adjacent cannabis-related verticals, with an eye toward becoming the default operating system for the industry. The potential take-private transaction is an important wild card, as it could reshape governance, strategy, and how aggressive the company can be with long-term investments. Overall, MAPS appears to be in a stabilization and refinement phase: solidifying its core business, improving efficiency, and cautiously building on its early-mover advantage in a still-evolving market.
NEWS
November 26, 2025 · 7:00 AM UTC
Optimi Health to Supply MDMA to MAPS Israel's Clinical Trial for Trauma-Related PTSD
Read more
November 6, 2025 · 4:05 PM UTC
WM Technology, Inc. Reports Financial Results for Third Quarter 2025
Read more
October 23, 2025 · 4:05 PM UTC
WM Technology, Inc. to Announce Third Quarter 2025 Financial Results via Webcast
Read more

CEO
Douglas Francis
Compensation Summary
(Year 2024)

CEO
Douglas Francis
Compensation Summary
(Year 2024)
Ratings Snapshot
Rating : A-
Most Recent Analyst Grades
Grade Summary
Price Target
Institutional Ownership

BLACKROCK, INC.
5.432M Shares
$4.601M

MORGAN STANLEY
5.367M Shares
$4.546M

VANGUARD GROUP INC
5.348M Shares
$4.53M

ETF MANAGERS GROUP, LLC
5.129M Shares
$4.344M

BLACKROCK INC.
4.622M Shares
$3.915M

SENVEST MANAGEMENT, LLC
3.197M Shares
$2.708M

SEGALL BRYANT & HAMILL, LLC
2.262M Shares
$1.916M

RENAISSANCE TECHNOLOGIES LLC
2.238M Shares
$1.895M

TOROSO INVESTMENTS, LLC
1.98M Shares
$1.677M

STATE STREET CORP
1.633M Shares
$1.383M

JPMORGAN CHASE & CO
1.512M Shares
$1.281M

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
1.378M Shares
$1.167M

REQUISITE CAPITAL MANAGEMENT, LLC
1.148M Shares
$971.96K

NORTHERN TRUST CORP
997.776K Shares
$845.116K

LOS ANGELES CAPITAL MANAGEMENT LLC
993.302K Shares
$841.327K

MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.
938.598K Shares
$794.993K

TWO SIGMA INVESTMENTS, LP
787.714K Shares
$667.194K

JACOB ASSET MANAGEMENT OF NEW YORK LLC
781.443K Shares
$661.882K

CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.
719.121K Shares
$609.095K

CAMBRIA INVESTMENT MANAGEMENT, L.P.
555.644K Shares
$470.63K
Summary
Only Showing The Top 20


